The most salient point in the Sloan Kettering Report was the last line:-
" “Assessing lesions using this molecular imaging-based approach ( via Convivo ) is non-invasive, safe, painless, and can potentially be used to accurately diagnose and manage the treatment of several cancers, including cervical cancer. PARPi-FL can be used to specifically identify cancer cells in real-time during colposcopy procedures and could serve as a more precise guide for biopsies or even to replace the need to biopsy altogether,” noted Paula Demetrio de Souza Franca, MD, visiting investigator at MSK.
The most salient point in the Sloan Kettering Report was the...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $171.2M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $15.10K | 75.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 292 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 16440 | 2 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| OIL (ASX) Chart |